Galderma Launches Sculptra in China
The launch follows regulatory approval and study results supporting Sculptra’s long-lasting correction of midface volume and contour loss.
The launch follows regulatory approval and study results supporting Sculptra’s long-lasting correction of midface volume and contour loss.
The reusable handpiece is now commercially available as part of the body contouring platform, which combines fat removal, electrosurgery, and Renuvion tissue contraction technology.